|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0390 USD | -21.69% |
|
-18.75% | -91.28% |
| 06-30 | ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-31 | ProPhase Labs, Inc. Auditor Raises 'Going Concern' Doubt | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROPHASE LABS, INC. | Medical & Diagnostic Laboratories | -21.69% | -18.75% | -91.28% | -98.62% | -99.94% | 698K |
-
|
-
|
-
|
- Stock Market
- Stocks
- PRPH Stock
- Charts ProPhase Labs, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
